97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

  
7 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02277223
(ClinicalTrials.gov)
March 1, 202025/10/2014Curcumin in Pediatric Ulcerative ColitisCurcumin for Induction and Maintenance Therapy in Pediatric Ulcerative ColitisUlcerative ColitisDietary Supplement: Curcumin;Drug: PlaceboSchneider Children's Medical Center, IsraelNULLWithdrawn6 Years18 YearsAll0Phase 3Israel
2ChiCTR1900022243
2019-04-012019-03-31Effect of curcumin combined with probiotics on prevention and treatment in ileal pouchitis after operation of ulcerative colitis.Effect of curcumin combined with probiotics on prevention and treatment in ileal pouchitis after operation of ulcerative colitis. ileal pouchitis after operation of ulcerative colitisExperimental group:Curcumin+Probiotics;Control group:Probiotics;Tianjin Medical University General HospitalNULLRecruitingBothExperimental group:20;Control group:10;China
3NCT03122613
(ClinicalTrials.gov)
June 19, 20177/4/2017Curcumin for Prevention of Relapse in Patients With Ulcerative ColitisA Double-blind, Randomized, Placebo-Controlled Trial of Curcumin Versus Placebo for Prevention of Relapse in Patients With Ulcerative ColitisUlcerative Colitis in RemissionDietary Supplement: Curcumin;Drug: PlaceboChinese University of Hong KongNULLRecruiting18 YearsN/AAll172N/AHong Kong
4NCT02683759
(ClinicalTrials.gov)
February 201610/2/2016Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative ColitisThe Efficacy and Tolerability of Bio-Enhanced Curcumin in Maintaining Remission in Patients With Ulcerative ColitisUlcerative ColitisDietary Supplement: Bio-enhanced Curcumin Soft Gelatin Capsule;Drug: 5-Aminosalicyclic acidAsian Institute of Gastroenterology, IndiaNULLRecruiting18 Years70 YearsBoth50Phase 3India
5NCT02683733
(ClinicalTrials.gov)
February 201610/2/2016Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative ColitisThe Efficacy and Tolerability of Bio-enhanced Curcumin (Diferuloylmethane) in the Induction of Remission in Patients With Mild to Moderate Ulcerative ColitisUlcerative ColitisDietary Supplement: Bio-enhanced Curcumin Soft Gelatin Capsule;Drug: 5-Aminosalicylic acidAsian Institute of Gastroenterology, IndiaNULLRecruiting18 Years70 YearsBoth50Phase 3India
6NCT01320436
(ClinicalTrials.gov)
July 201121/3/2011Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative ColitisRandomized, Double-blind, Placebo-controlled Study to Evaluated the Efficacy of Combining Curcumin+5ASA Medication Versus 5ASA Medication Alone on Active Mild to Moderate Ulcerative Colitis PatientsUlcerative ColitisDietary Supplement: Curcumin;Drug: 5-aminosalicylic acidSheba Medical CenterNULLCompleted18 Years70 YearsBoth50Phase 3Israel
7NCT00889161
(ClinicalTrials.gov)
May 200924/4/2009Curcumin in Pediatric Inflammatory Bowel DiseaseCurcumin in Pediatric Inflammatory Bowel Disease: A Forced Dose Titration StudyInflammatory Bowel Disease;Ulcerative Colitis;Crohn's DiseaseDrug: CurcuminSeattle Children's HospitalNULLCompleted8 Years18 YearsBoth11Phase 1United States